We are live on ! Find out more
INDV icon

Indivior Pharmaceuticals
INDV

60 hedge funds and large institutions have $1.86B invested in Indivior Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 60 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

44.95% more ownership

Funds ownership: 0% → 44.95% (+45%)

Holders
60
Holders Change
+60
Holders Change %
–
% of All Funds
0.94%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.08%
New
60
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TSC
Two Seas Capital
New York
+$313M
2
SCM
Scopia Capital Management
New York
+$220M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$132M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$82.1M
5
Goldman Sachs
Goldman Sachs
New York
+$80.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Axa
26
Axa
France
$10.1M +$9.72M +423,877 New
Swiss National Bank
27
Swiss National Bank
Switzerland
$6.6M +$6.54M +285,170 New
Citigroup
28
Citigroup
New York
$4.95M +$4.89M +213,426 New
CCP
29
Corbin Capital Partners
New York
$3.64M +$4.57M +199,574 New
HS
30
HighVista Strategies
Massachusetts
$3.09M +$2.98M +130,000 New
DekaBank Deutsche Girozentrale
31
DekaBank Deutsche Girozentrale
Germany
$2.96M +$3M +130,766 New
AFA
32
Alta Fundamental Advisers
New York
$2.73M +$3.44M +150,000 New
Geode Capital Management
33
Geode Capital Management
Massachusetts
$2.51M +$2.4M +104,604 New
RG
34
Renaissance Group
Kentucky
$2.26M +$2.18M +95,168 New
State of Tennessee, Department of Treasury
35
State of Tennessee, Department of Treasury
Tennessee
$2.15M +$2.13M +92,769 New
Envestnet Asset Management
36
Envestnet Asset Management
Illinois
$1.95M +$1.87M +81,678 New
DC
37
Diametric Capital
Massachusetts
$1.31M +$1.29M +56,467 New
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$915K +$881K +38,445 New
Aviva
39
Aviva
United Kingdom
$849K +$840K +36,635 New
Zurich Cantonal Bank
40
Zurich Cantonal Bank
Switzerland
$793K +$785K +34,231 New
RG
41
Rathbones Group
United Kingdom
$467K +$462K +20,140 New
SCM
42
Soleus Capital Management
Connecticut
$443K +$427K +18,624 New
Fidelity International
43
Fidelity International
Bermuda
$427K +$423K +18,444 New
DZ Bank
44
DZ Bank
Germany
$359K +$355K +15,490 New
CWA
45
CJM Wealth Advisers
Virginia
$312K +$300K +13,100 New
AllianceBernstein
46
AllianceBernstein
Tennessee
$310K +$299K +13,034 New
O
47
Ossiam
France
$288K +$285K +12,426 New
MAP
48
Madison Avenue Partners
New York
$267K +$257K +11,200 New
SIS
49
Susquehanna International Securities
Ireland
$249K +$238K +10,377 New
First Manhattan
50
First Manhattan
New York
$66.5K +$64.1K +2,795 New
1
2
3

INDV Hedge Fund Activity: Q2 2023 in Review

60 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Indivior Pharmaceuticals (INDV) for Q2 2023, worth a combined $1.86B.

Buyers outnumbered sellers: 60 funds opened new INDV positions and 0 closed out — a net gain of 60 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Two Seas Capital, opening a new position worth an estimated $313M.

  • 60 institutional investors held Indivior Pharmaceuticals (INDV) as of Q2 2023, up from 0 in Q1 2023.
  • Funds reported $1.86B of Indivior Pharmaceuticals stock for Q2 2023.
  • 60 funds opened new Indivior Pharmaceuticals positions in Q2 2023 and 0 closed out, a net change of +60 holders.
  • The largest Indivior Pharmaceuticals buyer in Q2 2023 was Two Seas Capital, an estimated $313M added.

Based on aggregated 13F filings for Q2 2023.